Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Navidea
Biotech
Xenotransplant firm eGenesis hires new R&D head—Chutes & Ladders
Xenotransplantation firm eGenesis hires new R&D head; Relay adds execs to chemistry, R&D; and Navidea brings on new CMO focused on imaging.
Conor Hale
Dec 7, 2018 10:00am
Navidea brings on new CMO focused on imaging biomarkers
Dec 7, 2018 7:33am
Navidea picks up $1M in Lymphoseek milestones
Sep 22, 2016 9:43am
Struggling Navidea to sell Lymphoseek to Cardinal Health for up to $310M
Sep 6, 2016 5:44pm
Slew of SEC filings show up widening cracks at Navidea
May 11, 2016 10:29am
